Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefiderocol vs imipenem/cilastatin for complicated urinary tract infection in Chinese adults
CTR20223300Phase 3Completed
- Sponsor
- 不适用/ 平安盐野义有限公司
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cefiderocol in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by 不适用/ 平安盐野义有限公司. Started Dec 2022; status: completed.
02
Drugs
cefiderocol
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20223300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223300.